Boston Scientific up on Q3 results beat, FY profit forecast raise

Boston Scientific

22/10/2025 14:59

Updates

** Shares of medical device maker Boston Scientific BSX.N rise 3.4% to $103.3

** Co reports Q3 adjusted profit of 75 cents per share, beating estimates of $71 cents per share, according to data compiled by LSEG

** Posts Q3 revenue of $5.06 billion vs an estimate of $4.96 billion

** BSX estimates YoY net sales growth for Q4  to be in a range of 11% to 13% on organic basis

** Co expects 2025 adjusted profit per share to be between $3.02 and $3.04, compared to its prior range of $2.95 to $2.99

** Including session's move, BSX stock up 14.7% YTD

(Reporting by Padmanabhan Ananthan)

((Padmanabhan.Ananthan@thomsonreuters.com))